{"id":521524,"date":"2020-12-07T18:38:01","date_gmt":"2020-12-07T18:38:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=521524"},"modified":"2020-12-07T18:38:01","modified_gmt":"2020-12-07T18:38:01","slug":"contract-research-organization-services-cros-market-worth-7377-billion-by-2025-key-players-are-iqvia-us-labcorp-us-parexel-us","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/contract-research-organization-services-cros-market-worth-7377-billion-by-2025-key-players-are-iqvia-us-labcorp-us-parexel-us_521524.html","title":{"rendered":"Contract Research Organization Services (CROs) Market Worth $73.77 Billion by 2025 | Key Players are IQVIA (US), LabCorp (US), PAREXEL (US)"},"content":{"rendered":"
\"Contract<\/a><\/p>\n
\n
The prominent players in the global CRO services market are IQVIA (US), LabCorp (US), PAREXEL (US), ICON plc (Ireland), PPD (US), PRA Health Sciences (US), Syneos Health (US), Charles River (US), Wuxi PharmaTech (US), Medpace Holdings (US), and SGS (Switzerland).<\/div>\n<\/div>\n<\/div>\n
Contract Research Organization Services (CROs) Market Size Estimation and Analysis of Wide Range of Growth Opportunities for Industry Players.<\/div>\n

According to the new market research report “Contract Research Organization Services (CROs) Market by Type (Discovery, CMC, Preclinical, Clinical Research, Laboratory Services), Therapeutic Area (Oncology, CNS, Cardiovascular), End User (Pharmaceuticals & Medical Device) – Global Forecast to 2025”<\/strong>, published by MarketsandMarkets™, the<\/strong> <\/strong>Contract Research Organization Services (CROs) Market is projected to reach USD 73.77 billion<\/span> by 2025 from USD 47.77 billion<\/span> in 2020, at a CAGR of 9.1% during the forecast period.<\/p>\n

<\/strong>Download PDF Brochure:
<\/strong>https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=167410116<\/a><\/p>\n

<\/strong>Increased outsourcing of R&D activities and increasing number of clinical trials are the major factors driving the growth of the CRO services market. The base year considered for the study is 2019, while, the forecast period is 2020 to 2025.<\/p>\n

<\/strong>By type, clinical research services segment accounted for the largest share of the CRO services market in 2019<\/p>\n

<\/strong>On the basis of type, clinical research services segment accounted for the largest share of the global CRO services market. This can be attributed to factors such as the growing biosimilar and biologics markets, increased R&D investments in pharmaceutical and biopharmaceutical companies, and increase in clinical trial activities.<\/p>\n

Browse in-depth TOC on<\/em> “<\/strong>Contract Research Organization Services (CROs) Market<\/a>“<\/p>\n

<\/strong>235 – Tables
<\/strong>52 – Figures
<\/strong>272 – Pages<\/p>\n

<\/strong>By therapeutic area, the oncology segment held the highest growth of the CRO services market in 2019<\/p>\n

<\/strong>On the basis of therapeutic area, the oncology segment accounted for the highest growth in this market. The highest growth of this segment is attributed to the increasing number of clinical trials and rising prevalence of cancer worldwide.<\/p>\n

The medical device companies segment is expected to witness the highest growth rate in the CRO services market, by end user, during the forecast period<\/p>\n

<\/strong>Based on end user, the medical device segment is expected to register the highest CAGR during the forecast period. Increasing incidence of chronic diseases, technological advancements in medical devices, and adoption of point-of-care (POC) testing are the major factors supporting the growth of this segment.<\/p>\n

Request Sample Pages:
<\/strong>https:\/\/www.marketsandmarkets.com\/requestCustomizationNew.asp?id=167410116<\/a><\/p>\n

North America<\/span> dominated the CRO services market in 2019<\/p>\n

<\/strong>North America<\/span> accounted for the largest share of the CRO services market in 2019, followed by Europe<\/span> and Asia Pacific<\/span>. High quality standards in the pharmaceutical industry, rising demand among pharmaceutical and biopharmaceutical companies for outsourcing services, and increase in clinical trial activities in the region are the major factors responsible for the large share of North America<\/span> in the CRO services market.<\/p>\n

The prominent players in the global CRO services market are IQVIA (US), LabCorp (US), PAREXEL (US), ICON plc (Ireland<\/span>), PPD (US), PRA Health Sciences (US), Syneos Health (US), Charles River<\/span> (US), Wuxi PharmaTech (US), Medpace Holdings (US), and SGS (Switzerland<\/span>).<\/p>\n

Media Contact<\/span>
Company Name:<\/strong> MarketsandMarkets<\/a>
Contact Person:<\/strong> Mr. Aashish Mehra
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> 18886006441
Address:<\/strong>630 Dundee Road Suite 430
City:<\/strong> Northbrook
State:<\/strong> IL 60062
Country:<\/strong> United States
Website:<\/strong> https:\/\/www.marketsandmarkets.com\/Market-Reports\/contract-research-organization-service-market-167410116.html<\/a><\/p>\n

<\/object>\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

The prominent players in the global CRO services market are IQVIA (US), LabCorp (US), PAREXEL (US), ICON plc (Ireland), PPD (US), PRA Health Sciences (US), Syneos Health (US), Charles River (US), Wuxi PharmaTech (US), Medpace Holdings (US), and SGS (Switzerland). … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,405,406,404,443],"tags":[],"class_list":["post-521524","post","type-post","status-publish","format-standard","hentry","category-Business","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-US","category-Website-Blog"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/521524","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=521524"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/521524\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=521524"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=521524"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=521524"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}